Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Taxes (2016 - 2025)

Sanofi (SNY) has disclosed Current Taxes for 11 consecutive years, with $874.2 million as the latest value for Q4 2025.

  • Quarterly Current Taxes rose 17.37% to $874.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $874.2 million through Dec 2025, up 17.37% year-over-year, with the annual reading at $848.5 million for FY2025, 12.47% up from the prior year.
  • Current Taxes hit $874.2 million in Q4 2025 for Sanofi, up from $744.8 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $874.2 million in Q4 2025 to a low of $353.5 million in Q4 2021.
  • Historically, Current Taxes has averaged $640.1 million across 5 years, with a median of $642.3 million in 2023.
  • Biggest five-year swings in Current Taxes: tumbled 50.91% in 2021 and later surged 65.67% in 2022.
  • Year by year, Current Taxes stood at $353.5 million in 2021, then surged by 65.67% to $585.6 million in 2022, then rose by 9.68% to $642.3 million in 2023, then increased by 15.95% to $744.8 million in 2024, then grew by 17.37% to $874.2 million in 2025.
  • Business Quant data shows Current Taxes for SNY at $874.2 million in Q4 2025, $744.8 million in Q4 2024, and $642.3 million in Q4 2023.